AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 141 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $30,004,000 | +2545.9% | 501,401 | +1140.0% | 0.03% | +2600.0% |
| Q3 2019 | $1,134,000 | -70.3% | 40,437 | -59.9% | 0.00% | -75.0% |
| Q2 2019 | $3,818,000 | -5.0% | 100,847 | -2.1% | 0.00% | 0.0% |
| Q1 2019 | $4,019,000 | +138.5% | 102,987 | +30.3% | 0.00% | +100.0% |
| Q4 2018 | $1,685,000 | -43.1% | 79,032 | +5.6% | 0.00% | -33.3% |
| Q3 2018 | $2,963,000 | +11.3% | 74,841 | +7.4% | 0.00% | 0.0% |
| Q2 2018 | $2,662,000 | +58.6% | 69,673 | +24.8% | 0.00% | +50.0% |
| Q1 2018 | $1,678,000 | – | 55,824 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $36,198,681,000 | 11.58% |
| Sofinnova Investments, Inc. | 1,380,303 | $41,478,000 | 7.13% |
| Casdin Capital, LLC | 450,000 | $13,523,000 | 2.38% |
| Foresite Capital Management III, LLC | 315,331 | $9,476,000 | 2.06% |
| Opaleye Management Inc. | 190,000 | $5,709,000 | 1.63% |
| Redmile Group, LLC | 1,308,526 | $39,321,000 | 1.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,384,470 | $41,603,000 | 1.44% |
| Orbimed Advisors | 3,522,100 | $105,839,000 | 1.31% |
| Rock Springs Capital Management LP | 565,000 | $16,978,000 | 0.72% |
| Cormorant Asset Management, LP | 322,945 | $9,704,000 | 0.72% |